Maron B J, Maron M S. Hypertrophic cardiomyopathy[J]. Lancet, 2013, 381(9862): 242-255. [2]Maron B J, Ommen S R, Semsarian C, et al. Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine[J]. J Am Coll Cardiol, 2014, 64(1): 83-99. [3]Efthimiadis G K, Giannakoulas G, Parcharidou D G, et al. Clinical significance of tissue Doppler imaging in patients with hypertrophic cardiomyopathy[J]. Circ J , 2007, 71(6):897-?903. [4]Elliott P M, Anastasakis A, Borger M A, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)[J]. Eur Heart J, 2014, 35(39):2733-2779. [5]Zou Y, Song L, Wang Z, et al. Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults[J]. Am J Med, 2004, 116(1): 14-18. [6]Graca B, Ferreira M J, Donato P, et al. Cardiovascular magnetic resonance imaging assessment of diastolic dysfunction in a population without heart disease: a gender-based study[J]. Eur Radiol, 2014, 24(1): 52-59. [7]Avegliano G, Costabel J P, Huguet M, et al. Influence of dynamic obstruction and hypertrophy location on diastolic function in hypertrophic cardiomyopathy[J]. J Cardiovasc Med (Hagerstown), 2014, 15(3): 207-213. [8]Olivotto I, Maron M S, Autore C, et al. Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy[J]. J Am Coll Cardiol, 2008, 52(7): 559-566. [9]Armstrong A C, Gidding S, Gjesdal O, et al. LV mass assessed by echocardiography and CMR, cardiovascular outcomes, and medical practice[J]. JACC Cardiovasc Imag, 2012, 5(8): 837-848. [10]Pritchett A M, Mahoney D W, Jacobsen S J, et al. Diastolic dysfunction and left atrial volume: a population-based study[J]. J Am Coll Cardiol, 2005, 45(1): 87-92. [11]Nistri S, Olivotto I, Betocchi S, et al. Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy)[J]. Am J Cardiol, 2006, 98(7): 960-965. [12]Yang W I, Shim C Y, Kim Y J, et al. Left atrial volume index: a predictor of adverse outcome in patients with hypertrophic cardiomyopathy[J]. J Am Soc Echocardiogr, 2009, 22(12): 1338-1343. [13]Caudron J, Fares J, Bauer F, et al. Evaluation of left ventricular diastolic function with cardiac MR imaging[J]. Radiographics, 2011, 31(1): 239-259. ?